We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

VERU Veru Inc

0.0449 (4.7%)
Dec 02 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 561,606
Bid Price 0.88
Ask Price 1.00
News -
Day High 1.01


52 Week Range


Day Low 0.92
Company Name Stock Ticker Symbol Market Type
Veru Inc VERU NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0449 4.7% 1.00 00:00:07
Open Price Low Price High Price Close Price Prev Close
0.9212 0.92 1.01 1.01 0.9551
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,692 561,606 $ 0.9798299 $ 550,278 - 0.6606 - 6.57
Last Trade Time Type Quantity Stock Price Currency
19:58:11 30 $ 1.00 USD

Veru Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
91.18M 90.28M - 39.35M -83.78M -0.93 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Veru News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No VERU Message Board. Create One! See More Posts on VERU Message Board See More Message Board Posts

Historical VERU Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.961.020.8905010.9520978659,8950.044.17%
1 Month0.991.140.880.9939982654,7960.011.01%
3 Months1.041.140.66060.8948139959,718-0.04-3.85%
6 Months1.001.450.66061.051,032,8290.000.0%
1 Year5.586.570.66062.531,876,599-4.58-82.08%
3 Years3.0324.560.660611.084,936,858-2.03-67.0%
5 Years1.5124.560.660610.753,082,198-0.51-33.77%

Veru Description

Veru Inc is a biopharmaceutical company focused on urology and oncology. It develops prescription products for benign prostatic hyperplasia hot flashes associated with cancer treatment, male infertility, and novel chemotherapies for a variety of cancers. The company currently operates in two reporting segments: Sexual health business and Research & development. Some of its products include Zuclomiphene, Veru-111, Veru-100, FC2, and Roman Swipes. The company generates the majority of its revenue from the United States.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |